New York, NY -- (SBWIRE) -- 11/20/2017 -- Chiral Chemicals Industry
Description
Wiseguyreports.Com Adds "Chiral Chemicals -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021" To Its Research Database
Chiral Chemicals Market research report focuses on the different methods and applications of Chiral Chemicals and their impact. Various Chiral Chemical preparation and separation methods include Traditional, Asymmetric, Biological and Other. Pharmaceuticals, Agrochemicals, Flavors/Fragrances are the different chiral chemical applications discussed. The study provides global market analysis for preparation of Chiral Chemicals by Traditional (Diastereomeric Crystallisation, Chromatography & Chiral Pool), Asymmetric (Synthesis & Catalysis) and Biological (Bio-catalysis & Kinetic Resolution). The study includes estimations and predictions for the total global Chiral Chemicals market. Market value for geographic regions including North America, Europe, Asia-Pacific, Japan, and Rest of World is also provided. The industry is analyzed in US Dollars and includes 183 exclusive exhibits. More than 500 companies are covered that are engaged in Chiral Chemical discovery, R&D, testing, and supply of products and services.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30788-chiral-chemicals-market-research-report
Report Highlights
Global Chiral Chemicals market is growing at a compounded annual growth rate (CAGR) of 13.1% during the analysis period 2005-2020. Chiral technology has made tremendous progress so much so that it can now be developed with ease. This has been made easier with the increase in chiral analytical techniques that are capable of differentiating between enantiomers either during development of the drug or while monitoring its results in the body. Despite the fact that chiral drugs have been in use much before the arrival of modern medicine, it is only now that chiral drugs in the pharmaceutical industry has gained so much attention. This is largely due to the understanding that enantiomers often show different bioactivity and metabolic fates. In addition there is also a commercial reason where pharmaceutical companies have the chance to extend patent coverage after expiry of patents on racemic drugs. This can take place through the development of the chiral switch enantiomers with suitable bioactivity. The usual protocol on drug design and development involves making the isomer mixtures first after which the preferred isomer is selected. Recently there have been many developments in medicinal chemistry that makes use of automated rapid synthesis. This is based on connecting building blocks in a particular manner and this is combined with automated bioscreening for therapeutic activity and selectivity determination. Information gathered must be exact to validate the use of single isomers. Today, synthetic and chiral drugs are commercially available. However, many of these chiral drugs are racemic mixtures. It is important for a chiral drug to be present in a pure therapeutically active form so as to avoid the possibility of any untoward effects. Therefore there is an urgency to develop a suitable technology for the analysis and separation of racemic drugs. The most important use of chiral technology is in its application in chiral drugs. Usually the most therapeutically effective form of a drug is the single enantiomer. Chiral technology now plays an important role in normal drug design by helping in not just the formation but also the discovery of new receptor-based as well as enzyme-inhibiting small molecule drugs. This is seen especially in drugs that require high selectivity of action. The availability of many new technologies in abundance instead of single-enantiomer chiral drugs makes this technology more acceptable.
Leave a Query @ https://www.wiseguyreports.com/enquiry/30788-chiral-chemicals-market-research-report
Report by Chapter
I. Scope and Methodology: This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
II. Report Synopsis: Report synopsis summarizes the global Chiral Chemicals market by Preparation & Separation Methods - Traditional, Asymmetric, and Biological and Application Areas - Pharmaceuticals, Agrochemicals, Flavors/Fragrances. The chapter also includes profiles of major companies and market analysis of Chiral Chemicals by geographic region including North America, Europe, Asia-Pacific and Rest of World.
III. Market Dynamics: Market Dynamics chapter provides information on global markets for Chiral Chemicals. The chapter includes global market analysis in US$ by geographic region; analysis of each region by both technology and product segment; brief business profiles of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.
IV. Product/Technology Research: This chapter gives an insight into various types of Chiral Chemicals including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities of Chiral chemicals in drug discovery and development. Various research activities in the field of Chiral Chemicals find a mention in this chapter.
V. Corporate Directory: This chapter provides a region-wise list of 400 plus companies, CROs and academic institutions that are engaged in Chiral Chemicals products and/or services.
VI. Patents Information: This chapter provides a compilation of worldwide patents related to Chiral Chemicals products/services.
Global Life Science Company Insight Profiles on Chiral Chemicals
Companies Discussed
41+ Chiral Chemicals Company Insight Profiles
507+ Company Directory Listing
Company Insight Profiles List
Agilent Technologies, Inc. (USA)
Albemarle Corporation (USA)
Alps Pharmaceutical Ind. Co., Ltd. (Japan)
Anhui Biochem United Pharmaceutical Co., Ltd. (China)
BASF SE (Germany)
Beckman Coulter, Inc (USA)
Boulder Scientific Company (USA)
Cambrex Corporation (USA)
Chiral Quest Corporation (USA)
Chiral Technologies, Inc. (USA)
Clariant AG (Switzerland)
Corden Pharma Switzerland LLC (Switzerland)
Daicel Chemical Industries Ltd. (Japan)
Dalco ChromTech AB (Sweden)
Digital Specialty Chemicals (Canada)
Dow Chemical Company (USA)
DSM Pharma (The Netherlands)
JASCO, Inc. (USA)
Johnson Matthey plc (UK)
Kingnord Industrial Limited (China)
Lonza Group AG (Switzerland)
Maxygen (USA)
NITTO DENKO Avecia Inc. (USA)
Novasep (France)
PDR-Chemical LLC (USA)
Pearce Pharmaceuticals (Australia)
PerkinElmer, Inc. (USA)
Phenomenex, Inc. (USA)
Regis Technologies, Inc. (USA)
RStech Corporation (South Korea)
Rudolph Instruments, Inc. (USA)
Shanghai Hanhong Chemical Co., Ltd. (China)
Sigma-Aldrich Co. LLC (USA)
SK Corporation (South Korea)
Solvay SA (Belgium)
Solvias AG (Switzerland)
Strem Chemicals, Inc. (USA)
Suven Life Sciences Limited (India)
Suzhou ChonTech PharmaChem Technology Co., Ltd. (China)
Synthetech, Inc. (USA)
Thermo Fisher Scientific, Inc. (USA)
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –
Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=30788
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)